RaySearch announced a 7-million-SEK ($670 million U.S.) deal with Pharmacolog AB for full ownership of DrugLog, a system that tracks the content and concentration of liquid medicine, such as chemotherapy.
In the announcement, RaySearch founder and CEO Johan Löf said the company will add DrugLog to treatment planning in RayStation and workflows in RayCare for chemotherapy management. Löf added that adding DrugLog will improve and simplify quality assurance in cancer treatment with chemotherapy.
The deal is specific to oncology and includes the measuring device, calibration parameters, source code, and intellectual property rights, according to RaySearch.
